Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 102.3 Million EUR | -4.12% |
| 2022 | 106.69 Million EUR | -4.25% |
| 2021 | 111.43 Million EUR | -2.5% |
| 2020 | 114.29 Million EUR | -8.14% |
| 2019 | 124.43 Million EUR | 0.12% |
| 2018 | 124.27 Million EUR | -2.25% |
| 2017 | 127.14 Million EUR | 2.5% |
| 2016 | 124.04 Million EUR | 0.63% |
| 2015 | 123.26 Million EUR | 1.01% |
| 2014 | 122.04 Million EUR | 7.46% |
| 2013 | 113.56 Million EUR | -0.33% |
| 2012 | 113.94 Million EUR | 2.74% |
| 2011 | 110.9 Million EUR | -0.81% |
| 2010 | 111.81 Million EUR | -0.87% |
| 2009 | 112.79 Million EUR | 2.72% |
| 2008 | 109.81 Million EUR | 3.2% |
| 2007 | 106.4 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 57.13 Million EUR | 0.0% |
| 2023 Q3 | 25.78 Million EUR | 1.51% |
| 2023 Q4 | 25.78 Million EUR | 0.0% |
| 2023 FY | 102.3 Million EUR | -4.12% |
| 2023 Q1 | 25.36 Million EUR | -50.98% |
| 2023 Q2 | 25.4 Million EUR | 0.16% |
| 2022 FY | 106.69 Million EUR | -4.25% |
| 2022 Q2 | 28.84 Million EUR | 4.99% |
| 2022 Q3 | 25.87 Million EUR | -10.31% |
| 2022 Q1 | 27.47 Million EUR | -49.94% |
| 2022 Q4 | 51.74 Million EUR | 100.0% |
| 2021 Q1 | 28.27 Million EUR | -52.13% |
| 2021 Q3 | 27.44 Million EUR | -2.84% |
| 2021 Q2 | 28.24 Million EUR | -0.1% |
| 2021 Q4 | 54.88 Million EUR | 100.0% |
| 2021 FY | 111.43 Million EUR | -2.5% |
| 2020 Q1 | 27.61 Million EUR | -55.45% |
| 2020 Q2 | 27.17 Million EUR | -1.62% |
| 2020 FY | 114.29 Million EUR | -8.14% |
| 2020 Q3 | 29.53 Million EUR | 8.7% |
| 2020 Q4 | 59.06 Million EUR | 100.0% |
| 2019 Q3 | 30.99 Million EUR | -1.73% |
| 2019 Q2 | 31.53 Million EUR | 1.01% |
| 2019 Q1 | 31.22 Million EUR | 0.12% |
| 2019 FY | 124.43 Million EUR | 0.12% |
| 2019 Q4 | 61.98 Million EUR | 100.0% |
| 2018 Q4 | 31.18 Million EUR | 0.0% |
| 2018 Q2 | 30.96 Million EUR | 0.04% |
| 2018 FY | 124.27 Million EUR | -2.25% |
| 2018 Q1 | 30.95 Million EUR | -2.69% |
| 2018 Q3 | 31.18 Million EUR | 0.7% |
| 2017 Q2 | 31.57 Million EUR | -0.6% |
| 2017 Q3 | 31.81 Million EUR | 0.76% |
| 2017 Q4 | 31.81 Million EUR | 0.0% |
| 2017 Q1 | 31.76 Million EUR | 1.54% |
| 2017 FY | 127.14 Million EUR | 2.5% |
| 2016 Q4 | 31.27 Million EUR | 0.0% |
| 2016 FY | 124.04 Million EUR | 0.63% |
| 2016 Q2 | 31.03 Million EUR | 0.94% |
| 2016 Q3 | 31.27 Million EUR | 0.8% |
| 2016 Q1 | 30.74 Million EUR | -0.26% |
| 2015 Q4 | 30.82 Million EUR | -1.63% |
| 2015 FY | 123.26 Million EUR | 1.01% |
| 2015 Q3 | 31.33 Million EUR | 2.11% |
| 2015 Q2 | 30.68 Million EUR | 0.87% |
| 2015 Q1 | 30.42 Million EUR | -1.87% |
| 2014 Q4 | 31 Million EUR | -1.66% |
| 2014 Q3 | 31.52 Million EUR | 3.22% |
| 2014 Q2 | 30.54 Million EUR | 5.31% |
| 2014 Q1 | 29 Million EUR | -0.1% |
| 2014 FY | 122.04 Million EUR | 7.46% |
| 2013 Q4 | 29.02 Million EUR | -0.2% |
| 2013 Q3 | 29.08 Million EUR | 2.96% |
| 2013 Q2 | 28.25 Million EUR | 3.88% |
| 2013 Q1 | 27.19 Million EUR | -4.12% |
| 2013 FY | 113.56 Million EUR | -0.33% |
| 2012 Q1 | 27.63 Million EUR | -0.37% |
| 2012 Q2 | 28.41 Million EUR | 2.81% |
| 2012 Q3 | 29.52 Million EUR | 3.9% |
| 2012 FY | 113.94 Million EUR | 2.74% |
| 2012 Q4 | 28.36 Million EUR | -3.91% |
| 2011 Q4 | 27.74 Million EUR | -1.68% |
| 2011 Q3 | 28.21 Million EUR | 1.85% |
| 2011 Q2 | 27.7 Million EUR | 1.68% |
| 2011 FY | 110.9 Million EUR | -0.81% |
| 2011 Q1 | 27.24 Million EUR | -0.65% |
| 2010 FY | 111.81 Million EUR | -0.87% |
| 2010 Q4 | 27.42 Million EUR | -5.26% |
| 2010 Q3 | 28.94 Million EUR | 1.93% |
| 2010 Q2 | 28.39 Million EUR | 5.0% |
| 2010 Q1 | 27.04 Million EUR | 0.0% |
| 2009 FY | 112.79 Million EUR | 2.72% |
| 2008 FY | 109.81 Million EUR | 3.2% |
| 2007 FY | 106.4 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.45 Billion EUR | 99.474% |
| Fresenius SE & Co. KGaA | 22.29 Billion EUR | 99.541% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -175.216% |
| M1 Kliniken AG | 316.31 Million EUR | 67.657% |
| MEDICLIN Aktiengesellschaft | 761.59 Million EUR | 86.567% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.73 Billion EUR | 94.102% |
| VITA 34 AG | 77.06 Million EUR | -32.758% |